Technical analysis of Stryker Corporation (SYK): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries.
Price Performance
| 1 month | -16.05% |
| 3 months | -10.62% |
| Year-to-date | -21.72% |
| 1 year | -26.99% |
| 3 years | -4.79% |
| 5 years | +2.53% |
52-Week Range
| 52-week High | $392.55 |
| 52-week Low | $267.00 |
| Avg Volume (90d) | 2.7M |
Technical Indicators
| SMA 50 | $320.40 |
| SMA 200 | $334.39 |
| Beta | 0.93 |
| 30-day Volatility (annualised) | 36.0% |
| Price vs SMA 50 | -14.1% |
| Price vs SMA 200 | -17.7% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $356.24 | |
| 2025-11 | $371.18 | +4.2% |
| 2025-12 | $351.47 | -5.3% |
| 2026-01 | $369.56 | +5.1% |
| 2026-02 | $387.46 | +4.8% |
| 2026-03 | $328.59 | -15.2% |
| 2026-04 | $315.13 | -4.1% |
| 2026-05 | $305.09 | -3.2% |
| 2026-06 | $314.84 | +3.2% |
| 2026-07 | $325.70 | +3.4% |
| 2026-08 | $323.80 | -0.6% |
| 2026-09 | $275.12 | -15.0% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-16 | $-0.11 | $723M |
| 2026-09-16 | | $17M |
| 2026-09-16 | $0.91 | $1.44B |
| 2026-09-16 | | |
| 2026-09-16 | | |
| 2026-09-16 | $-3.22 | $9M |
Price
| Price | $275.12 |
| Market Cap | $105.5B |
| Exchange | NYSE |
| Country | US |
Valuation Ratios
| P/E Ratio | 27.82 |
| Price / Book | 4.33 |
| EV / EBITDA | 19.02 |
| Dividend Yield | 1.29% |
Financial Health
| Debt / Equity | 0.62 |
| Current Ratio | 2.16 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 4.81 |